Work

Preliminary Results from a Phase Ib Study of Isatuximab in Combination with Pomalidomide and Dexamethasone in Relapsed and Refractory Multiple Myeloma

Year: 2016

Type: article

Study design: Clinical Trial

Source: Blood

DOI: 10.1182/blood.v128.22.2123.2123

Authors: Paul G. Richardson, Joseph Mikhael, Saad Z Usmani, Noopur Raje, William Bensinger, Frank Campana, Lei Gao, Franck Dubin, Claudine Wack, Kenneth C. Anderson

Institutions: Harvard University, Dana-Farber Cancer Institute, Mayo Clinic Hospital, Mayo Clinic Comprehensive Cancer Center (Arizona), Carolinas Healthcare System, Levine Cancer Institute, Massachusetts General Hospital, Sanofi (France)

Language: English

Topic: Multiple Myeloma Research and Treatments

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4244469595

FWCI: 5.54

Cites:

Cited by: 22

Related to: 10